BrightSpring Health Services, Inc.— Sankey Diagram
Quarterly mode · period ending 2026-03-31 · SEC EDGAR
ComparingFY2026 (Q4) vs FY2025 (Q4)
Revenue
$3.61B
↑+25.6% +$736Mvs FY2025 (Q4)
Gross Profit
$482M
↑+42.5% +$144Mvs FY2025 (Q4)
Operating Income
$121M
↑+139.4% +$71Mvs FY2025 (Q4)
Net Income
$74M
↑+750.3% +$66Mvs FY2025 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2026 (Q4) | FY2025 (Q4) |
|---|---|---|
| Revenue | $3.61B | $2.88B |
| COGS | $3.13B | $2.54B |
| Gross Profit | $482M | $338M |
| R&D | $0 | $0 |
| SG&A | $361M | $288M |
| D&A | $0 | $0 |
| Other OpEx | $0 | $0 |
| Operating Income | $121M | $51M |
| Interest Exp. | $39M | $42M |
| Other Non-Op | $0 | $0 |
| Pretax Income | $83M | $9M |
| Tax | $9M | $240K |
| Net Income | $74M | $9M |
QuarterCharts · SEC EDGAR data · BTSG · Comparing FY2026 (Q4) vs FY2025 (Q4)